아세트아미노펜 주사제 시장 규모 조사 및 예측 : 유형별, 용도별, 지역별 분석(2023-2030년)

Global Acetaminophen Injection Market is valued at approximately USD 698.92 million in 2022 and is anticipated to grow with a healthy growth rate of more than 2.97% over during the forecast period 2023-2030. Acetaminophen Injection is a widely used analgesic pain reliever and antipyretic fever reducing medication. The injection form is administered intravenously, directly into the bloodstream, providing a rapid onset of action. The Acetaminophen Injection market Market is expanding because of factors such as the growing number of geriatric population and the rising demand of for analgesic drugs for pain relief. Acetaminophen Injection is typically employed in situations where oral administration of medications is not feasible to or may be less effective. This could include instances where patients are unable to take medications orally, such as in post-operative care, critical care settings, or when there is a need for quick and precise pain relief. As a result, the demand of for Acetaminophen Injection has progressively increased in the international market during the forecast period 2023-2030.

Geriatric individuals may could have difficulty tolerating or properly absorbing oral medications due to issues such as gastrointestinal problems, difficulty swallowing, or a higher likelihood of taking multiple medications. Acetaminophen Injections offer an alternative route of administration, ensuring rapid and direct relief without relying on oral absorption. According to the World Health Organization indicates that the global population aged 60 and above is expected to double to around 2.1 billion by 2050. Moreover, those aged 80 and beyond are anticipated to triple between 2020 and 2050, reaching a staggering 426 million. Another important factor that drives the Acetaminophen Injection market Market is the increasing demand of for analgesic drugs for pain relief. The intravenous administration of Acetaminophen Injection allows for a quicker onset of action compared to oral formulations. This rapid relief can be crucial in emergency situationsemergencies, post-operative care, or critical care scenarios, driving the preference for Acetaminophen Injection in healthcare settings. In addition, as per Statista, the global Analgesics Market accounts for USD 25.61 billion in 2020 and the market is projected to reach up to USD 43.62 billion by the year 2028. Moreover, growing healthcare expenditure towards the development of pain reliefs and increasing awareness among healthcare professionals towards the usage of Acetaminophen Injections is are anticipated to create a lucrative growth opportunity opportunities for the market over the forecast period. However, High development cost costs associated to with Acetaminophen and Side effects due to overdose of Acetaminophen is are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Acetaminophen Injection Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of research and development activities towards pain relief drugs in the region. Researchers may explore combination therapies that incorporate Acetaminophen with other analgesics or complementary medications. This can result in synergistic effects, providing better pain relief and potentially expanding the applications of Acetaminophen Injections in different clinical scenarios. The region's dominant performance is anticipated to propel the overall demand of for Acetaminophen Injection. Furthermore, Asia Pacific is expected to grow fastest during over the forecast period, owing to factors such as rising government healthcare expenditure in the region. Government funding can contribute to the development and maintenance of emergency and intensive care facilities. Acetaminophen Injections are commonly used in these settings, and improved facilities may drive the demand for such medications.

Major market player included in this report are:

• Mallinckrodt Pharmaceuticals
• Sandoz International GmbH
• Pfizer Inc
• Fresenius Kabi AG
• Terumo Corporation
• B. Braun Melsungen AG
• Eugia Pharma Specialities Limited
• Accord Healthcare Limited
• Hikma Pharmaceuticals PLC
• AuroMedics Pharma LLC

Recent Developments in the Market:

• In December 2020, Leucadia Pharmaceuticals has introduced a generic version of Ofirmev (Mallinckrodt Pharmaceuticals), an FDA-approved acetaminophen injection available in a 1000 mg/100 mL (10 mg/mL) dosage. This launch signifies an expansion in Leucadia's portfolio of FDA-approved generic injections. The acetaminophen injection is designed to address mild-to-moderate pain, manage moderate-to-severe pain when used alongside opioid analgesics, and reduce fever. Leucadia emphasizes that its generic version is AP ratedAP-rated, equipped with barcoding, devoid of preservatives, and does not contain natural rubber latex. This addition to Leucadia's product line complements their existing range of FDA-approved generic injections, which includes the pioneering generic valrubicin sterile solution for intravesical instillation, a generic sodium tetradecyl sulfate injection, and a generic icatibant injection.

Global Acetaminophen Injection Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Type

• 10 mg/ mL
• 100 mg/mL
• 150 mg/mL

by Application

• Hospital
• Clinic

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1.Acetaminophen Injection Market, by Region, 2020-2030 (USD Million)
  • 1.2.2.Acetaminophen Injection Market, by Type, 2020-2030 (USD Million)
  • 1.2.3.Acetaminophen Injection Market, by Application, 2020-2030 (USD Million)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Acetaminophen Injection Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Acetaminophen Injection Market Dynamics

• 3.1.Acetaminophen Injection Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Growing number of geriatric population
    • 3.1.1.2.Rising demand of for analgesic drugs for pain relief
  • 3.1.2.Market Challenges
    • 3.1.2.1.High development cost associated to with Acetaminophen
    • 3.1.2.2.Side effects due to overdose of Acetaminophen
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Growing healthcare expenditure towards development of pain reliefs relief
    • 3.1.3.2.Increasing awareness among healthcare professionals towards usage of Acetaminophen Injections

Chapter 4.Global Acetaminophen Injection Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Acetaminophen Injection Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Acetaminophen Injection Market by Type, Performance - Potential Analysis
• 5.3.Global Acetaminophen Injection Market Estimates & Forecasts by Type 2020-2030 (USD Million)
• 5.4.Acetaminophen Injection Market, Sub Segment Analysis
  • 5.4.1.10 mg/ mL
  • 5.4.2.100 mg/mL
  • 5.4.3.150 mg/mL

Chapter 6.Global Acetaminophen Injection Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Acetaminophen Injection Market by Application, Performance - Potential Analysis
• 6.3.Global Acetaminophen Injection Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 6.4.Acetaminophen Injection Market, Sub Segment Analysis
  • 6.4.1.Hospital
  • 6.4.2.Clinic

Chapter 7.Global Acetaminophen Injection Market, Regional Analysis

• 7.1.Top Leading Countries
• 7.2.Top Emerging Countries
• 7.3.Acetaminophen Injection Market, Regional Market Snapshot
• 7.4.North America Acetaminophen Injection Market
  • 7.4.1.U.S. Acetaminophen Injection Market
    • 7.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2.Application breakdown estimates & forecasts, 2020-2030
  • 7.4.2.Canada Acetaminophen Injection Market
• 7.5.Europe Acetaminophen Injection Market Snapshot
  • 7.5.1.U.K. Acetaminophen Injection Market
  • 7.5.2.Germany Acetaminophen Injection Market
  • 7.5.3.France Acetaminophen Injection Market
  • 7.5.4.Spain Acetaminophen Injection Market
  • 7.5.5.Italy Acetaminophen Injection Market
  • 7.5.6.Rest of Europe Acetaminophen Injection Market
• 7.6.Asia-Pacific Acetaminophen Injection Market Snapshot
  • 7.6.1.China Acetaminophen Injection Market
  • 7.6.2.India Acetaminophen Injection Market
  • 7.6.3.Japan Acetaminophen Injection Market
  • 7.6.4.Australia Acetaminophen Injection Market
  • 7.6.5.South Korea Acetaminophen Injection Market
  • 7.6.6.Rest of Asia Pacific Acetaminophen Injection Market
• 7.7.Latin America Acetaminophen Injection Market Snapshot
  • 7.7.1.Brazil Acetaminophen Injection Market
  • 7.7.2.Mexico Acetaminophen Injection Market
• 7.8.Middle East & Africa Acetaminophen Injection Market
  • 7.8.1.Saudi Arabia Acetaminophen Injection Market
  • 7.8.2.South Africa Acetaminophen Injection Market
  • 7.8.3.Rest of Middle East & Africa Acetaminophen Injection Market

Chapter 8.Competitive Intelligence

• 8.1.Key Company SWOT Analysis
• 8.2.Top Market Strategies
• 8.3.Company Profiles
  • 8.3.1.Mallinckrodt Pharmaceuticals
    • 8.3.1.1.Key Information
    • 8.3.1.2.Overview
    • 8.3.1.3.Financial (Subject to Data Availability)
    • 8.3.1.4.Product Summary
    • 8.3.1.5.Recent Developments
  • 8.3.2.Sandoz International GmbH
  • 8.3.3.Pfizer Inc
  • 8.3.4.Fresenius Kabi AG
  • 8.3.5.Terumo Corporation
  • 8.3.6.B. Braun Melsungen AG
  • 8.3.7.Eugia Pharma Specialities Limited
  • 8.3.8.Accord Healthcare Limited
  • 8.3.9.Hikma Pharmaceuticals PLC
  • 8.3.10.AuroMedics Pharma LLC

Chapter 9.Research Process

• 9.1.Research Process
  • 9.1.1.Data Mining
  • 9.1.2.Analysis
  • 9.1.3.Market Estimation
  • 9.1.4.Validation
  • 9.1.5.Publishing
• 9.2.Research Attributes
• 9.3.Research Assumption